Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pregnancy and Economic Outcomes in Patients Treated for Recurrent Preterm Labor

Journal of Perinatology volume 24, pages 223–227 (2004)Cite this article

Abstract

OBJECTIVE: To compare clinical and cost-effectiveness of treating recurrent preterm labor (RPTL) with oral nifedipine versus continuous subcutaneous terbutaline infusion (SQT).

STUDY DESIGN: Women with singleton gestations prescribed nifedipine for tocolysis following first diagnosis of preterm labor were identified. Women hospitalized with RPTL at <34 weeks were matched by gestational age (GA) after resuming nifedipine (NIF group) with women prescribed SQT (SQT group) after stabilization. Healthcare utilization costs were modeled and compared.

RESULTS: This study analyzed 142 matched pairs. GA at RPTL (matched variable) was 30.4±2.6 weeks. GA at delivery was earlier in the NIF group versus the SQT group (35.7±3.1 weeks versus 36.6±2.1 weeks, p=0.004). Overall, infants from the NIF group had lower birth weights and higher nursery days than infants from the SQT group. Healthcare utilization costs were greater in the NIF group versus the SQT group ($37,040±47,518 versus 26,546±25,386, p=0.014).

CONCLUSION: Treating RPTL with SQT versus oral nifedipine resulted in a later GA at delivery, improved neonatal outcome, and increased cost-effectiveness.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Berkowitz GS, Papiernik E . Epidemiology of preterm birth. Epidemiol Rev 1993;15:414–443.

    Article  CAS  Google Scholar 

  2. Hearne AE, Nagey DA . Therapeutic agents in preterm labor: tocolytic agents. Clin Obstet Gynecol 2000;43:787–801.

    Article  CAS  Google Scholar 

  3. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B . Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001;97:840–847.

    CAS  PubMed  Google Scholar 

  4. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I . Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol 1999;181:484–490.

    Article  CAS  Google Scholar 

  5. Kupferminc M, Lessing JB, Yaron Y, Peyser MR . Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol 1993;100:1090–1094.

    Article  CAS  Google Scholar 

  6. Carr DB, Clark AL, Kernek K, Spinnato JA . Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 1999;181:822–827.

    Article  CAS  Google Scholar 

  7. St. John EB, Nelson KG, Cliver SP, Bishnoi RR, Goldenberg RL . Cost of neonatal care according to gestational age at birth and survival status. Am J Obstet Gynecol 2000;182:170–175.

    Article  CAS  Google Scholar 

  8. Martin JA, Hamilton BE, Ventura SA, Menacker F, Park MM . Births: Final data for 2000. National Vital Statistics Reports; Vol 50, No. 5. Hyattsville, MD: National Center for Health Statistics; 2002.

  9. HCUPnet, Healthcare Cost and Utilization Project. Nationwide Inpatient Sample, 1999. Rockville, MD: Agency for Healthcare Research and Quality, 1999.

  10. Hill WC . Risks and complications of tocolysis. Clin Obstet Gynecol 1995;38:725–745.

    Article  CAS  Google Scholar 

  11. Wischnik A . Risk−benefit assessment of tocolytic drugs. Drug Saf 1991;6:371–381.

    Article  CAS  Google Scholar 

  12. Davis WB, Wells SR, Kuller JA, Thorp JM . Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist. Obstet Gynecol Surv 1997;52:198–201.

    Article  CAS  Google Scholar 

  13. Perry KG, Morrison JC, Rust OA, Sullivan CA, Martin RW, Naef RW . Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 1995;173:1273–1277.

    Article  CAS  Google Scholar 

  14. Ferguson JE, Dyson DC, Holbrook RH, Schutz T, Stevenson DK . Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol 1989;161:788–795.

    Article  Google Scholar 

  15. Papatsonis DNM, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA . Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:230–234.

    Article  CAS  Google Scholar 

  16. Glock JL, Morales WJ . Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993;169:960–964.

    Article  CAS  Google Scholar 

  17. Idama TO, Lindow SW . Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. Br J Obstet Gynaecol 1998;105:260–268.

    Article  CAS  Google Scholar 

  18. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC . The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838–842.

    Article  CAS  Google Scholar 

  19. Lam F, Gill PJ, Smith M, Kitzmiller JL, Katz M . Use of subcutaneous terbutaline pump for long term tocolysis. Obstet Gynecol 1988;72:810–812.

    CAS  PubMed  Google Scholar 

  20. Moise Jr KJ, Sala DJ, Zurawin RK, Cano LE, Hesketh DE, Carpenter RJ . Continuous subcutaneous terbutaline pump for premature labor: safety and efficacy. S Med J 1992;85:255–260.

    Article  Google Scholar 

  21. Allbert JR, Wise CA, Lou CH, Gookin KS, Parmenter MA, Morrison JC . Subcutaneous tocolytic infusion therapy for patients at high risk for preterm birth. J Perinatol 1992;12:28–31.

    CAS  PubMed  Google Scholar 

  22. Adkins RT, Van Hooydonk JE, Bressman PL, et al. Prevention of preterm birth: early detection and aggressive treatment with terbutaline. S Med J 1993;86:157–164.

    Article  CAS  Google Scholar 

  23. Allbert JR, Johnson C, Roberts WE, Martin RW, Gookin KS, Morrison JC . Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump. J Reprod Med 1994;39:614–618.

    CAS  PubMed  Google Scholar 

  24. Elliott JP, Flynn MJ, Kaemmerer EL, Radin TG . Terbutaline pump tocolysis in high-order multiple gestation. J Reprod Med 1997;42:687–694.

    CAS  PubMed  Google Scholar 

  25. Wenstrom KD, Weiner CP, Merrill D, Neibyl J . A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. J Perinatol 1997;14:87–91.

    Article  CAS  Google Scholar 

  26. Lam F, Bergauer NK, Stanziano GJ, Jacques DL . Pregnancy prolongation and route of tocolytic administration in patients with singleton gestation. Am J Obstet Gynecol 1998;178:180.

    Article  Google Scholar 

  27. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC . Terbutaline pump maintenance therapy for prevention of preterm delivery: a double blind trial. Am J Obstet Gynecol 1998;179:874–878.

    Article  CAS  Google Scholar 

  28. Lam F, Bergauer NK, Coleman SK, Stanziano GJ, Jacques DL . A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations. J Perinatol 2000;20:408–413.

    Article  CAS  Google Scholar 

  29. Elliott JP, Bergauer NK, Jacques DL, Coleman SK, Stanziano GJ . Pregnancy prolongation in triplet pregnancies: oral vs. continuous subcutaneous terbutaline. J Reprod Med 2001;46:975–982.

    CAS  PubMed  Google Scholar 

  30. Bracero LA, Leikin E, Kirshenbaum N, Tejani N . Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol 1991;8:365–369.

    Article  CAS  Google Scholar 

  31. El-Sayed YY, Holbrook RH, Gibson R, Chitkara U, Druzin ML, Baba D . Diltiazem for maintenance tocolysis of preterm labor: comparison to nifedipine in a randomized trial. J Matern-Fetal Med 1998;7:217–221.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Creighton University Medical Center, Omaha, NE, USA

    Alfred Fleming MD & Robert Bonebrake MD

  2. Matria Healthcare Inc., Marietta, GA, USA

    Niki Istwan RN, BS, Debbie Rhea MPH, Suzanne Coleman MSc, RNC & Gary Stanziano MD

Authors
  1. Alfred Fleming MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Bonebrake MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Niki Istwan RN, BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Debbie Rhea MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suzanne Coleman MSc, RNC
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gary Stanziano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fleming, A., Bonebrake, R., Istwan, N. et al. Pregnancy and Economic Outcomes in Patients Treated for Recurrent Preterm Labor. J Perinatol 24, 223–227 (2004). https://doi.org/10.1038/sj.jp.7211058

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211058

This article is cited by

Search

Advanced search

Quick links